市場調査レポート

商品コード

1475009

エフェドリン硫酸塩市場：純度別、投与様式別、適応疾患別、地域別、機会、予測、2017年～2031年

Ephedrine Sulfate Market Assessment, By Purity, By Mode of Administration, By Disease Indication, By Region, Opportunities and Forecast, 2017-2031F

出版日: 2024年05月08日
発行: Market Xcel - Markets and Data
ページ情報: 英文 230 Pages
納期: 3～5営業日

カスタマイズ可能

価格

PDF & Excel Printable (Single User License)

USD 4,800 691,584円

レポートPDFを1名の方がご利用頂けるライセンスです。レポートPDFのパスワード保護はありません。PDF内のテキスト等のコピー＆ペーストは可能です。印刷は無制限で可能です。Excelのデータがライセンスに含まれています。

PDF & Excel Printable (Corporate License)

USD 6,000 864,480円

レポートPDFを企業の１カ国の拠点のすべての方がご利用頂けるライセンスです。レポートPDFのパスワード保護はありません。PDF内のテキスト等のコピー＆ペーストは可能ですが、企業内部での利用に限定されます。ご利用に際しては、あらかじめ出版社の許諾を得る必要があります。詳細はお問合せください。印刷は可能です。Excelのデータがライセンスに含まれています。

PDF & Excel Printable (Custom Research License)

USD 8,500 1,224,680円

レポートPDFを企業の１カ国の拠点のすべての方がご利用頂けるライセンスです。レポートPDFのパスワード保護はありません。PDF内のテキスト等のコピー＆ペーストは可能です。印刷は無制限で可能です。Excelのデータがライセンスに含まれています。アナリストアワー100時間が含まれており、レポートのカスタマイズなどにご利用いただけます。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=144.08円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

世界のエフェドリン硫酸塩の市場規模は、予測期間の2024年～2031年に6.1％のCAGRで拡大し、2023年の1億2,245万米ドルから2031年には1億9,664万米ドルに成長すると予測されています。市場の成長を支えているのは、脊椎麻酔による低血圧の有病率の上昇と気管支喘息の症例の増加です。

気管支喘息の有病率の上昇は、世界のエフェドリン硫酸塩市場の主要動向です。気管支喘息は慢性炎症性疾患で、さまざまな程度の気道閉塞と気管支亢進を特徴とします。気管支喘息は、気管支活動の測定や可逆性試験を含む肺機能検査、身体診察、化学的履歴に基づいて診断されます。例えば、オーストラリア統計局は、2022年には280万人弱が喘息患者であると推定しています。喘息患者数の増加により、エフェドリン硫酸塩の需要は急速に増加しています。エフェドリンは去痰薬および気管支拡張薬として機能し、空気の通り道を広げ、軽度の喘息患者が呼吸しやすくなるようにします。そのため、製品需要が高まり、さまざまな地域での市場成長が後押しされています。

脊椎麻酔施行時の低血圧の発生件数の増加は、世界のエフェドリン硫酸塩市場の需要を押し上げる主な要因の1つです。例えば、2021年に発表された前向き観察研究では、帝王切開の際に脊椎麻酔が提供されたケースの76％で低血圧が報告されたことが示されています。エフェドリンは、臨床的に重大な低血圧を管理・治療するために使用され、脊椎麻酔や硬膜外麻酔による低血圧に選択される薬剤です。エフェドリンのボーラス投与は、帝王切開を受ける患者の脊髄誘発性低血圧の予防に有効です。そのため、エフェドリン硫酸塩の需要が高まり、症状の調整に不可欠な薬剤の製造が確実に行われるようになり、市場の成長が促進されます。

当レポートでは、世界のエフェドリン硫酸塩市場について調査し、市場の概要とともに、純度別、投与様式別、適応疾患別、地域別動向、および市場に参入する企業のプロファイルなどを提供しています。

List of Tables

Table 1. Pricing Analysis of Products from Key Players
Table 2. Competition Matrix of Top 5 Market Leaders
Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

Figure 1.Global Ephedrine Sulfate Market, By Value, in USD Million, 2017-2031F
Figure 2.Global Ephedrine Sulfate Market, By Volume, in Kilotons, 2017-2031F
Figure 3.Global Ephedrine Sulfate Market Share (%), By Purity, 2017-2031F
Figure 4.Global Ephedrine Sulfate Market Share (%), By Mode of Administration, 2017-2031F
Figure 5.Global Ephedrine Sulfate Market Share (%), By Disease Indication, 2017-2031F
Figure 6.Global Ephedrine Sulfate Market Share (%), By Region, 2017-2031F
Figure 7.North America Ephedrine Sulfate Market, By Value, in USD Million, 2017-2031F
Figure 8.North America Ephedrine Sulfate Market, By Volume, in Kilotons, 2017-2031F
Figure 9.North America Ephedrine Sulfate Market Share (%), By Purity, 2017-2031F
Figure 10.North America Ephedrine Sulfate Market Share (%), By Mode of Administration, 2017-2031F
Figure 11.North America Ephedrine Sulfate Market Share (%), By Disease Indication, 2017-2031F
Figure 12.North America Ephedrine Sulfate Market Share (%), By Country, 2017-2031F
Figure 13.United States Ephedrine Sulfate Market, By Value, in USD Million, 2017-2031F
Figure 14.United States Ephedrine Sulfate Market, By Volume, in Kilotons, 2017-2031F
Figure 15.United States Ephedrine Sulfate Market Share (%), By Purity, 2017-2031F
Figure 16.United States Ephedrine Sulfate Market Share (%), By Mode of Administration, 2017-2031F
Figure 17.United States Ephedrine Sulfate Market Share (%), By Disease Indication, 2017-2031F
Figure 18.Canada Ephedrine Sulfate Market, By Value, in USD Million, 2017-2031F
Figure 19.Canada Ephedrine Sulfate Market, By Volume, in Kilotons, 2017-2031F
Figure 20.Canada Ephedrine Sulfate Market Share (%), By Purity, 2017-2031F
Figure 21.Canada Ephedrine Sulfate Market Share (%), By Mode of Administration, 2017-2031F
Figure 22.Canada Ephedrine Sulfate Market Share (%), By Disease Indication, 2017-2031F
Figure 23.Mexico Ephedrine Sulfate Market, By Value, in USD Million, 2017-2031F
Figure 24.Mexico Ephedrine Sulfate Market, By Volume, in Kilotons, 2017-2031F
Figure 25.Mexico Ephedrine Sulfate Market Share (%), By Purity, 2017-2031F
Figure 26.Mexico Ephedrine Sulfate Market Share (%), By Mode of Administration, 2017-2031F
Figure 27.Mexico Ephedrine Sulfate Market Share (%), By Disease Indication, 2017-2031F
Figure 28.Europe Ephedrine Sulfate Market, By Value, in USD Million, 2017-2031F
Figure 29.Europe Ephedrine Sulfate Market, By Volume, in Kilotons, 2017-2031F
Figure 30.Europe Ephedrine Sulfate Market Share (%), By Purity, 2017-2031F
Figure 31.Europe Ephedrine Sulfate Market Share (%), By Mode of Administration, 2017-2031F
Figure 32.Europe Ephedrine Sulfate Market Share (%), By Disease Indication, 2017-2031F
Figure 33.Europe Ephedrine Sulfate Market Share (%), By Country, 2017-2031F
Figure 34.Germany Ephedrine Sulfate Market, By Value, in USD Million, 2017-2031F
Figure 35.Germany Ephedrine Sulfate Market, By Volume, in Kilotons, 2017-2031F
Figure 36.Germany Ephedrine Sulfate Market Share (%), By Purity, 2017-2031F
Figure 37.Germany Ephedrine Sulfate Market Share (%), By Mode of Administration, 2017-2031F
Figure 38.Germany Ephedrine Sulfate Market Share (%), By Disease Indication, 2017-2031F
Figure 39.France Ephedrine Sulfate Market, By Value, in USD Million, 2017-2031F
Figure 40.France Ephedrine Sulfate Market, By Volume, in Kilotons, 2017-2031F
Figure 41.France Ephedrine Sulfate Market Share (%), By Purity, 2017-2031F
Figure 42.France Ephedrine Sulfate Market Share (%), By Mode of Administration, 2017-2031F
Figure 43.France Ephedrine Sulfate Market Share (%), By Disease Indication, 2017-2031F
Figure 44.Italy Ephedrine Sulfate Market, By Value, in USD Million, 2017-2031F
Figure 45.Italy Ephedrine Sulfate Market, By Volume, in Kilotons, 2017-2031F
Figure 46.Italy Ephedrine Sulfate Market Share (%), By Purity, 2017-2031F
Figure 47.Italy Ephedrine Sulfate Market Share (%), By Mode of Administration, 2017-2031F
Figure 48.Italy Ephedrine Sulfate Market Share (%), By Disease Indication, 2017-2031F
Figure 49.United Kingdom Ephedrine Sulfate Market, By Value, in USD Million, 2017-2031F
Figure 50.United Kingdom Ephedrine Sulfate Market, By Volume, in Kilotons, 2017-2031F
Figure 51.United Kingdom Ephedrine Sulfate Market Share (%), By Purity, 2017-2031F
Figure 52.United Kingdom Ephedrine Sulfate Market Share (%), By Mode of Administration, 2017-2031F
Figure 53.United Kingdom Ephedrine Sulfate Market Share (%), By Disease Indication, 2017-2031F
Figure 54.Russia Ephedrine Sulfate Market, By Value, in USD Million, 2017-2031F
Figure 55.Russia Ephedrine Sulfate Market, By Volume, in Kilotons, 2017-2031F
Figure 56.Russia Ephedrine Sulfate Market Share (%), By Purity, 2017-2031F
Figure 57.Russia Ephedrine Sulfate Market Share (%), By Mode of Administration, 2017-2031F
Figure 58.Russia Ephedrine Sulfate Market Share (%), By Disease Indication, 2017-2031F
Figure 59.Netherlands Ephedrine Sulfate Market, By Value, in USD Million, 2017-2031F
Figure 60.Netherlands Ephedrine Sulfate Market, By Volume, in Kilotons, 2017-2031F
Figure 61.Netherlands Ephedrine Sulfate Market Share (%), By Purity, 2017-2031F
Figure 62.Netherlands Ephedrine Sulfate Market Share (%), By Mode of Administration, 2017-2031F
Figure 63.Netherlands Ephedrine Sulfate Market Share (%), By Disease Indication, 2017-2031F
Figure 64.Spain Ephedrine Sulfate Market, By Value, in USD Million, 2017-2031F
Figure 65.Spain Ephedrine Sulfate Market, By Volume, in Kilotons, 2017-2031F
Figure 66.Spain Ephedrine Sulfate Market Share (%), By Purity, 2017-2031F
Figure 67.Spain Ephedrine Sulfate Market Share (%), By Mode of Administration, 2017-2031F
Figure 68.Spain Ephedrine Sulfate Market Share (%), By Disease Indication, 2017-2031F
Figure 69.Turkey Ephedrine Sulfate Market, By Value, in USD Million, 2017-2031F
Figure 70.Turkey Ephedrine Sulfate Market, By Volume, in Kilotons, 2017-2031F
Figure 71.Turkey Ephedrine Sulfate Market Share (%), By Purity, 2017-2031F
Figure 72.Turkey Ephedrine Sulfate Market Share (%), By Mode of Administration, 2017-2031F
Figure 73.Turkey Ephedrine Sulfate Market Share (%), By Disease Indication, 2017-2031F
Figure 74.Poland Ephedrine Sulfate Market, By Value, in USD Million, 2017-2031F
Figure 75.Poland Ephedrine Sulfate Market, By Volume, in Kilotons, 2017-2031F
Figure 76.Poland Ephedrine Sulfate Market Share (%), By Purity, 2017-2031F
Figure 77.Poland Ephedrine Sulfate Market Share (%), By Mode of Administration, 2017-2031F
Figure 78.Poland Ephedrine Sulfate Market Share (%), By Disease Indication, 2017-2031F
Figure 79.South America Ephedrine Sulfate Market, By Value, in USD Million, 2017-2031F
Figure 80.South America Ephedrine Sulfate Market, By Volume, in Kilotons, 2017-2031F
Figure 81.South America Ephedrine Sulfate Market Share (%), By Purity, 2017-2031F
Figure 82.South America Ephedrine Sulfate Market Share (%), By Mode of Administration, 2017-2031F
Figure 83.South America Ephedrine Sulfate Market Share (%), By Disease Indication, 2017-2031F
Figure 84.South America Ephedrine Sulfate Market Share (%), By Country, 2017-2031F
Figure 85.Brazil Ephedrine Sulfate Market, By Value, in USD Million, 2017-2031F
Figure 86.Brazil Ephedrine Sulfate Market, By Volume, in Kilotons, 2017-2031F
Figure 87.Brazil Ephedrine Sulfate Market Share (%), By Purity, 2017-2031F
Figure 88.Brazil Ephedrine Sulfate Market Share (%), By Mode of Administration, 2017-2031F
Figure 89.Brazil Ephedrine Sulfate Market Share (%), By Disease Indication, 2017-2031F
Figure 90.Argentina Ephedrine Sulfate Market, By Value, in USD Million, 2017-2031F
Figure 91.Argentina Ephedrine Sulfate Market, By Volume, in Kilotons, 2017-2031F
Figure 92.Argentina Ephedrine Sulfate Market Share (%), By Purity, 2017-2031F
Figure 93.Argentina Ephedrine Sulfate Market Share (%), By Mode of Administration, 2017-2031F
Figure 94.Argentina Ephedrine Sulfate Market Share (%), By Disease Indication, 2017-2031F
Figure 95.Asia-Pacific Ephedrine Sulfate Market, By Value, in USD Million, 2017-2031F
Figure 96.Asia-Pacific Ephedrine Sulfate Market, By Volume, in Kilotons, 2017-2031F
Figure 97.Asia-Pacific Ephedrine Sulfate Market Share (%), By Purity, 2017-2031F
Figure 98.Asia-Pacific Ephedrine Sulfate Market Share (%), By Mode of Administration, 2017-2031F
Figure 99.Asia-Pacific Ephedrine Sulfate Market Share (%), By Disease Indication, 2017-2031F
Figure 100.Asia-Pacific Ephedrine Sulfate Market Share (%), By Country, 2017-2031F
Figure 101.India Ephedrine Sulfate Market, By Value, in USD Million, 2017-2031F
Figure 102.India Ephedrine Sulfate Market, By Volume, in Kilotons, 2017-2031F
Figure 103.India Ephedrine Sulfate Market Share (%), By Purity, 2017-2031F
Figure 104.India Ephedrine Sulfate Market Share (%), By Mode of Administration, 2017-2031F
Figure 105.India Ephedrine Sulfate Market Share (%), By Disease Indication, 2017-2031F
Figure 106.China Ephedrine Sulfate Market, By Value, in USD Million, 2017-2031F
Figure 107.China Ephedrine Sulfate Market, By Volume, in Kilotons, 2017-2031F
Figure 108.China Ephedrine Sulfate Market Share (%), By Purity, 2017-2031F
Figure 109.China Ephedrine Sulfate Market Share (%), By Mode of Administration, 2017-2031F
Figure 110.China Ephedrine Sulfate Market Share (%), By Disease Indication, 2017-2031F
Figure 111.Japan Ephedrine Sulfate Market, By Value, in USD Million, 2017-2031F
Figure 112.Japan Ephedrine Sulfate Market, By Volume, in Kilotons, 2017-2031F
Figure 113.Japan Ephedrine Sulfate Market Share (%), By Purity, 2017-2031F
Figure 114.Japan Ephedrine Sulfate Market Share (%), By Mode of Administration, 2017-2031F
Figure 115.Japan Ephedrine Sulfate Market Share (%), By Disease Indication, 2017-2031F
Figure 116.Australia Ephedrine Sulfate Market, By Value, in USD Million, 2017-2031F
Figure 117.Australia Ephedrine Sulfate Market, By Volume, in Kilotons, 2017-2031F
Figure 118.Australia Ephedrine Sulfate Market Share (%), By Purity, 2017-2031F
Figure 119.Australia Ephedrine Sulfate Market Share (%), By Mode of Administration, 2017-2031F
Figure 120.Australia Ephedrine Sulfate Market Share (%), By Disease Indication, 2017-2031F
Figure 121.Vietnam Ephedrine Sulfate Market, By Value, in USD Million, 2017-2031F
Figure 122.Vietnam Ephedrine Sulfate Market, By Volume, in Kilotons, 2017-2031F
Figure 123.Vietnam Ephedrine Sulfate Market Share (%), By Purity, 2017-2031F
Figure 124.Vietnam Ephedrine Sulfate Market Share (%), By Mode of Administration, 2017-2031F
Figure 125.Vietnam Ephedrine Sulfate Market Share (%), By Disease Indication, 2017-2031F
Figure 126.South Korea Ephedrine Sulfate Market, By Value, in USD Million, 2017-2031F
Figure 127.South Korea Ephedrine Sulfate Market, By Volume, in Kilotons, 2017-2031F
Figure 128.South Korea Ephedrine Sulfate Market Share (%), By Purity, 2017-2031F
Figure 129.South Korea Ephedrine Sulfate Market Share (%), By Mode of Administration, 2017-2031F
Figure 130.South Korea Ephedrine Sulfate Market Share (%), By Disease Indication, 2017-2031F
Figure 131.Indonesia Ephedrine Sulfate Market, By Value, in USD Million, 2017-2031F
Figure 132.Indonesia Ephedrine Sulfate Market, By Volume, in Kilotons, 2017-2031F
Figure 133.Indonesia Ephedrine Sulfate Market Share (%), By Purity, 2017-2031F
Figure 134.Indonesia Ephedrine Sulfate Market Share (%), By Mode of Administration, 2017-2031F
Figure 135.Indonesia Ephedrine Sulfate Market Share (%), By Disease Indication, 2017-2031F
Figure 136.Philippines Ephedrine Sulfate Market, By Value, in USD Million, 2017-2031F
Figure 137.Philippines Ephedrine Sulfate Market, By Volume, in Kilotons, 2017-2031F
Figure 138.Philippines Ephedrine Sulfate Market Share (%), By Purity, 2017-2031F
Figure 139.Philippines Ephedrine Sulfate Market Share (%), By Mode of Administration, 2017-2031F
Figure 140.Philippines Ephedrine Sulfate Market Share (%), By Disease Indication, 2017-2031F
Figure 141.Middle East & Africa Ephedrine Sulfate Market, By Value, in USD Million, 2017-2031F
Figure 142.Middle East & Africa Ephedrine Sulfate Market, By Volume, in Kilotons, 2017-2031F
Figure 143.Middle East & Africa Ephedrine Sulfate Market Share (%), By Purity, 2017-2031F
Figure 144.Middle East & Africa Ephedrine Sulfate Market Share (%), By Mode of Administration, 2017-2031F
Figure 145.Middle East & Africa Ephedrine Sulfate Market Share (%), By Disease Indication, 2017-2031F
Figure 146.Middle East & Africa Ephedrine Sulfate Market Share (%), By Country, 2017-2031F
Figure 147.Saudi Arabia Ephedrine Sulfate Market, By Value, in USD Million, 2017-2031F
Figure 148.Saudi Arabia Ephedrine Sulfate Market, By Volume, in Kilotons, 2017-2031F
Figure 149.Saudi Arabia Ephedrine Sulfate Market Share (%), By Purity, 2017-2031F
Figure 150.Saudi Arabia Ephedrine Sulfate Market Share (%), By Mode of Administration, 2017-2031F
Figure 151.Saudi Arabia Ephedrine Sulfate Market Share (%), By Disease Indication, 2017-2031F
Figure 152.UAE Ephedrine Sulfate Market, By Value, in USD Million, 2017-2031F
Figure 153.UAE Ephedrine Sulfate Market, By Volume, in Kilotons, 2017-2031F
Figure 154.UAE Ephedrine Sulfate Market Share (%), By Purity, 2017-2031F
Figure 155.UAE Ephedrine Sulfate Market Share (%), By Mode of Administration, 2017-2031F
Figure 156.UAE Ephedrine Sulfate Market Share (%), By Disease Indication, 2017-2031F
Figure 157.South Africa Ephedrine Sulfate Market, By Value, in USD Million, 2017-2031F
Figure 158.South Africa Ephedrine Sulfate Market, By Volume, in Kilotons, 2017-2031F
Figure 159.South Africa Ephedrine Sulfate Market Share (%), By Purity, 2017-2031F
Figure 160.South Africa Ephedrine Sulfate Market Share (%), By Mode of Administration, 2017-2031F
Figure 161.South Africa Ephedrine Sulfate Market Share (%), By Disease Indication, 2017-2031F
Figure 162.By Purity Map-Market Size (USD Million) & Growth Rate (%), 2023
Figure 163.By Mode of Administration Map-Market Size (USD Million) & Growth Rate (%), 2023
Figure 164.By Disease Indication Map-Market Size (USD Million) & Growth Rate (%), 2023
Figure 165.By Region Map-Market Size (USD Million) & Growth Rate (%), 2023

Product Code: MX11276

Global ephedrine sulfate market is projected to witness a CAGR of 6.1% during the forecast period 2024-2031, growing from USD 122.45 million in 2023 to USD 196.64 million in 2031F. The market growth is supported by the increasing prevalence of spinal anesthesia-induced hypotension and rising cases of bronchial asthma.

The increasing prevalence of bronchial asthma is a leading global ephedrine sulfate market trend. Bronchial asthma, a chronic inflammatory disease, is characterized by variable degrees of airway obstruction and bronchial hyperactivity. The condition is diagnosed based on pulmonary test functions, including measurement of bronchial activity and reversibility testing, physical examination, and chemical history. For instance, the Australian Bureau of Statistics estimates that under 2.8 million individuals were asthmatic in 2022. Due to the rise in the number of cases of asthma, the requirement for ephedrine sulfate is witnessing a rapid increase as ephedrine works as an expectorant and bronchodilator, opening the air passages and allowing individuals with mild asthma to breathe more easily. Thus, boosting the product demand and supporting market growth in various regions.

Moreover, the rapid expansion of the pharmaceutical sector in various regions across the globe is further bolstering the growth of the market. For instance, according to Invest India, the Indian pharmaceutical industry is expected to reach USD 130 billion by 2030. The growth propels the requirement of ephedrine sulfate as this beta and alpha-adrenergic agonist can enhance the release of norepinephrine. The chemical has been used for urinary incontinence, heart failure, and rhinitis and is deployed for treating depression and narcolepsy, because of the central nervous system stimulatory effects that it offers. Due to the advantages and applications offered by the product, it is increasingly being used by the pharmaceutical sector, thus augmenting market expansion.

Increase in Incidences of Hypotension During Provision of Spinal Anesthesia

The rising incidences of hypotension during the provision of spinal anesthesia are one of the major factors boosting the global ephedrine sulfate market demand. For instance, a prospective observational study published in 2021 showed that hypotension was reported in 76% of the cases where spinal anesthesia was provided during cesarean section. Ephedrine is used for managing and treating clinically significant hypotension and is the agent of choice for spinal or epidural anesthesia induced hypotension. Ephedrine administered as bolus dose is efficacious in preventing spinal-induced hypotension in patients that are undergoing cesarean section. Thus, bolstering the demand for ephedrine sulfate to ensure the manufacturing of the drugs essential for regulating the condition and propelling the growth of the market.

Expansion of Pharmaceutical Sector Will Boost the Global Ephedrine Sulfate Market Growth

The rapid expansion of the pharmaceutical sector in the region will provide lucrative growth opportunities for the market over the forecast period. For instance, the Association of the British Pharmaceutical Industry estimates that the pharmaceutical industry in the United Kingdom has a turnover of USD 51.7 billion (GBP 40.8 billion). Due to this rapid expansion of the pharmaceutical industry, the demand for ephedrine sulfate is increasing as the product finds various applications in the pharmaceutical sector. Ephedrine belongs to the sympathomimetic class of drugs and is used for treating and managing clinically significant hypotension. Also, the chemical is approved for treating hypotension secondary to spinal anesthesia and reversible bronchospasm and bronchial asthma. Thus, augmenting the product demand from the pharmaceutical sector.

North America Holds Significant Market Share

The expansion of the pharmaceutical sector, increase in number of cases of asthma, and growing emphasis on research and development activities are some of the major factors supporting the growth of North America ephedrine sulfate market. For instance, the Asthma and Allergy Foundation of America estimates that in 2022, approximately 1 in 13 people in the United States, approximately 26 million people, had asthma. The increase is boosting the requirement for ephedrine sulfate as for treating asthma, every four hours, 25 mg tablets of ephedrine sulfate are required, while the maximum dose should not exceed 150 mg in 24 hours. For adults, the intramuscular doses for prolonged desired effects are 25-50 mg and dose recommendations for bolus are 5-10 mg. Thus, augmenting the demand for ephedrine sulfate in the region.

Additionally, the increasing provision of approval by the US Food and Drug Administration (FDA) for treating hypotension in anesthesia settings with ephedrine sulfate injections is further aiding the growth of the market in North America. For instance, in March 2023, Nexus Pharmaceuticals, Inc. announced they received approval from the FDA for EMERPHED. The pre-filled single-dose syringes are available in 50mg/10mL and 25mg/5mL. The provision of such approvals by the FDA, therefore, provides lucrative growth opportunities to the market.

Above 99% Pure Ephedrine Sulfate to Account for Significant Market Share

The rising requirement for ephedrine sulfate, which has above 99% purity, can be attributed to various applications offered by chemicals in the pharmaceutical sector. Ephedrine increases blood pressure by stimulating cardiac output and heart rate and variably augmenting peripheral resistance. It causes bronchodilation due to the activation of beta-adrenergic receptors present in the lungs. The therapeutic window of ephedrine is large, as patients can receive doses from 5mg to 50 mg. The increasing requirement for ephedrine sulfate injections to treat and manage clinically important hypotension induced by anesthesia further supports the segment's expansion.

Moreover, the rapid expansion of the pharmaceutical sector in various regions across the globe is further propelling the requirement for ephedrine sulfate with above 99% purity. For instance, in 2021, 49.1% of global pharmaceutical sales were accounted for by North America, and approximately 23.4% were accounted for by Europe. Due to the increase in sales of pharmaceutical products, the requirement for ephedrine sulfate with above 99% purity is augmenting as the chemical finds applications in various drugs. Thus, propelling the growth of the segment and boosting the market demand.

Increasing Prevalence of Bronchial Asthma Boosts Global Ephedrine Sulfate Market Size

The rise in the number of individuals suffering from bronchial asthma provides lucrative growth opportunities for the market. For instance, the American College of Allergy, Asthma and Immunology estimates that approximately 7.7% of Americans, or 24.9 million people, had asthma in 2023; of these, approximately 4.6 million are children, and 20.2 million are adults. The increase in the number of cases of asthma is thus propelling the requirement for ephedrine sulfate as the beta and alpha-adrenergic agonist is used for relieving acute bronchospasm. Ephedrine sulfate oral tablets are indicated for providing temporary relief against the mild symptoms of intermittent asthma, such as shortness of breath, episodic wheezing, and tightness of the chest. Due to such advantages, the demand for ephedrine sulfate tablets is rising in managing asthma symptoms and enhancing patient comfort. Thus, augmenting the requirement for ephedrine sulfate for manufacturing the tablets to meet the growing demand of the patients and propelling the market expansion.

Future Market Scenario (2024 - 2031F)

According to global ephedrine sulfate market analysis, the increase in research and development activities to test the efficacy of treatment solutions derived from ephedrine sulfate will boost the expansion of the market over the forecast period. For instance, KK Women's and Children's Hospital, based in Singapore, is conducting an interventional study to develop a novel algorithm for an advanced DIVA (ADIVA) system for rigorously controlling blood pressure by detecting blood pressure with a stable hemodynamic profile. The automated delivery system will administer ephedrine and phenylephrine via a three-step algorithm vasopressor technique. When the systolic blood pressure is between 90-110% of baseline, 2mg of ephedrine will be given either in bolus or infusion if the heart rate less than 60 beats/ min. In the situation where the systolic blood pressure is less than 90% of the baseline 2-6 mg of ephedrine will be given either in bolus or infusion if the heart rate less than 60 beats/ min. The experiment is expected to conclude in December 2024. Such studies will aid in evaluating the functioning of drugs derived from ephedrine sulfate, propelling the demand for the product, and boosting the global ephedrine sulfate market growth.

Key Players Landscape and Outlook

The increasing provision of approval by the various regulatory bodies for the usage of ephedrine sulfate injections, among others, is supporting the expansion of market players. For instance, in 2023, Zydus Lifesciences Limited, received approval from the USFDA for ephedrine sulfate injections. These injections are indicated for treating hypotension occurring due to anesthesia. The company received approval from the regulatory body to market and manufacture ephedrine sulfate injection USP, 50 mg/ mL single-dose vials. Such approvals are propelling the requirement for ephedrine sulfate and providing lucrative growth opportunities to the market.

1.Research Methodology

2.Project Scope & Definitions

3.Executive Summary

4.Voice of Customer

4.1.Market Awareness and Product Information
4.2.Brand Awareness and Loyalty
4.3.Factors Considered in Purchase Decision
- 4.3.1.Brand Name
- 4.3.2.Quality
- 4.3.3.Quantity
- 4.3.4.Price
- 4.3.5.Product Specification
- 4.3.6.Form Specification
- 4.3.7.Shelf Life
- 4.3.8.Availability of Product
4.4.Frequency of Purchase
4.5.Medium of Purchase

5.Global Ephedrine Sulfate Market Outlook, 2017-2031F

5.1.Market Size & Forecast
- 5.1.1.By Value
- 5.1.2.By Volume
5.2.By Purity
- 5.2.1.Less than 98%
- 5.2.2.98% to 99%
- 5.2.3.Above 99%
5.3.By Mode of Administration
- 5.3.1.Intravenous Injections
- 5.3.2.Nasal Spray
5.4.By Disease Indication
- 5.4.1.Spinal Anesthesia-Induced Hypotension
- 5.4.2.Nasal Congestion
- 5.4.3.Bronchial Asthma
- 5.4.4.Others
5.5.By Region
- 5.5.1.North America
- 5.5.2.South America
- 5.5.3.Europe
- 5.5.4.Asia-Pacific
- 5.5.5.Middle East & Africa
5.6.By Company Market Share (%), 2023

6.Global Ephedrine Sulfate Market Outlook, By Region, 2017-2031F

6.1.North America*
- 6.1.1.Market Size & Forecast
  - 6.1.1.1.By Value
  - 6.1.1.2.By Volume
- 6.1.2.By Purity
  - 6.1.2.1.Less than 98%
  - 6.1.2.2.98% to 99%
  - 6.1.2.3.Above 99%
- 6.1.3.By Mode of Administration
  - 6.1.3.1.Intravenous Injections
  - 6.1.3.2.Nasal Spray
- 6.1.4.By Disease Indication
  - 6.1.4.1.Spinal Anesthesia-Induced Hypotension
  - 6.1.4.2.Nasal Congestion
  - 6.1.4.3.Bronchial Asthma
  - 6.1.4.4.Others
- 6.1.5.United States*
  - 6.1.5.1.Market Size & Forecast
    - 6.1.5.1.1.By Value
    - 6.1.5.1.2.By Volume
  - 6.1.5.2.By Purity
    - 6.1.5.2.1.Less than 98%
    - 6.1.5.2.2.98% to 99%
    - 6.1.5.2.3.Above 99%
  - 6.1.5.3.By Mode of Administration
    - 6.1.5.3.1.Intravenous Injections
    - 6.1.5.3.2.Nasal Spray
  - 6.1.5.4.By Disease Indication
    - 6.1.5.4.1.Spinal Anesthesia-Induced Hypotension
    - 6.1.5.4.2.Nasal Congestion
    - 6.1.5.4.3.Bronchial Asthma
    - 6.1.5.4.4.Others
- 6.1.6.Canada
- 6.1.7.Mexico

All segments will be provided for all regions and countries covered

6.2.Europe
- 6.2.1.Germany
- 6.2.2.France
- 6.2.3.Italy
- 6.2.4.United Kingdom
- 6.2.5.Russia
- 6.2.6.Netherlands
- 6.2.7.Spain
- 6.2.8.Turkey
- 6.2.9.Poland
6.3.Asia-Pacific
- 6.3.1.India
- 6.3.2.China
- 6.3.3.Japan
- 6.3.4.Australia
- 6.3.5.Vietnam
- 6.3.6.South Korea
- 6.3.7.Indonesia
- 6.3.8.Philippines
6.4.South America
- 6.4.1.Brazil
- 6.4.2.Argentina
6.5.Middle East & Africa
- 6.5.1.Saudi Arabia
- 6.5.2.UAE
- 6.5.3.South Africa

7.Supply Side Analysis

7.1.Capacity, By Company
7.2.Production, By Company
7.3.Operating Efficiency, By Company
7.4.Key Plant Locations (Up to 25)

8.Market Mapping, 2023

8.1.By Purity
8.2.By Mode of Administration
8.3.By Disease Indication
8.4.By Region

9.Macro Environment and Industry Structure

9.1.Supply Demand Analysis
9.2.Import Export Analysis
9.3.Supply Chain Analysis
9.4.PESTEL Analysis
- 9.4.1.Political Factors
- 9.4.2.Economic System
- 9.4.3.Social Implications
- 9.4.4.Technological Advancements
- 9.4.5.Environmental Impacts
- 9.4.6.Legal Compliances and Regulatory Policies (Statutory Bodies Included)
9.5.Porter's Five Forces Analysis
- 9.5.1.Supplier Power
- 9.5.2.Buyer Power
- 9.5.3.Substitution Threat
- 9.5.4.Threat from New Entrant
- 9.5.5.Competitive Rivalry

10.Market Dynamics

10.1.Growth Drivers
10.2.Growth Inhibitors (Challenges and Restraints)

11.Key Players Landscape

11.1.Competition Matrix of Top Five Market Leaders
11.2.Market Revenue Analysis of Top Five Market Leaders (in %, 2023)
11.3.Mergers and Acquisitions/Joint Ventures (If Applicable)
11.4.SWOT Analysis (For Five Market Players)
11.5.Patent Analysis (If Applicable)

12.Pricing Analysis

13.Case Studies

14.Key Players Outlook

14.1.Spectrum Chemical Mfg. Corp. (Spectrum Laboratory Products, Inc.)
- 14.1.1.Company Details
- 14.1.2.Key Management Personnel
- 14.1.3.Products & Services
- 14.1.4.Financials (As reported)
- 14.1.5.Key Market Focus & Geographical Presence
- 14.1.6.Recent Developments
14.2.Taj Pharmaceutical Limited
14.3.Sigma- Aldrich (Merck KGaA)
14.4.Biosynth
14.5.Midas Pharma
14.6.Malladi Drugs & Pharmaceuticals Ltd.
14.7.Embio Limited
14.8.Siegfried Holding AG
14.9.Nortec Quimica S.A.
14.10.Cymit Quimica S.L.

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work

エフェドリン硫酸塩市場：純度別、投与様式別、適応疾患別、地域別、機会、予測、2017年～2031年

Ephedrine Sulfate Market Assessment, By Purity, By Mode of Administration, By Disease Indication, By Region, Opportunities and Forecast, 2017-2031F

目次

第1章調査手法

第2章プロジェクトの範囲と定義

第3章エグゼクティブサマリー

第4章顧客の声

第5章世界のエフェドリン硫酸塩市場の見通し、2017年～2031年

第6章世界のエフェドリン硫酸塩市場の見通し、地域別、2017年～2031年

第7章供給側分析

第8章市場マッピング、2023年

第9章マクロ環境と産業構造

第10章市場力学

第11章主要参入企業の情勢

第12章価格分析

第13章ケーススタディ

第14章主要参入企業の見通し

第15章戦略的提言

第16章お問い合わせと免責事項

List of Tables

List of Figures

Table of Contents

1.Research Methodology

2.Project Scope & Definitions

3.Executive Summary

4.Voice of Customer

5.Global Ephedrine Sulfate Market Outlook, 2017-2031F

6.Global Ephedrine Sulfate Market Outlook, By Region, 2017-2031F

7.Supply Side Analysis

8.Market Mapping, 2023

9.Macro Environment and Industry Structure

10.Market Dynamics

11.Key Players Landscape

12.Pricing Analysis

13.Case Studies

14.Key Players Outlook

15.Strategic Recommendations

16.About Us & Disclaimer

エフェドリン硫酸塩市場：純度別、投与様式別、適応疾患別、地域別、機会、予測、2017年～2031年

Ephedrine Sulfate Market Assessment, By Purity, By Mode of Administration, By Disease Indication, By Region, Opportunities and Forecast, 2017-2031F

目次

第1章 調査手法

第2章 プロジェクトの範囲と定義

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 世界のエフェドリン硫酸塩市場の見通し、2017年～2031年

第6章 世界のエフェドリン硫酸塩市場の見通し、地域別、2017年～2031年

第7章 供給側分析

第8章 市場マッピング、2023年

第9章 マクロ環境と産業構造

第10章 市場力学

第11章 主要参入企業の情勢

第12章 価格分析

第13章 ケーススタディ

第14章 主要参入企業の見通し

第15章 戦略的提言

第16章 お問い合わせと免責事項

List of Tables

List of Figures

Table of Contents

1.Research Methodology

2.Project Scope & Definitions

3.Executive Summary

4.Voice of Customer

5.Global Ephedrine Sulfate Market Outlook, 2017-2031F

6.Global Ephedrine Sulfate Market Outlook, By Region, 2017-2031F

7.Supply Side Analysis

8.Market Mapping, 2023

9.Macro Environment and Industry Structure

10.Market Dynamics

11.Key Players Landscape

12.Pricing Analysis

13.Case Studies

14.Key Players Outlook

15.Strategic Recommendations

16.About Us & Disclaimer

第1章調査手法

第2章プロジェクトの範囲と定義

第3章エグゼクティブサマリー

第4章顧客の声

第5章世界のエフェドリン硫酸塩市場の見通し、2017年～2031年

第6章世界のエフェドリン硫酸塩市場の見通し、地域別、2017年～2031年

第7章供給側分析

第8章市場マッピング、2023年

第9章マクロ環境と産業構造

第10章市場力学

第11章主要参入企業の情勢

第12章価格分析

第13章ケーススタディ

第14章主要参入企業の見通し

第15章戦略的提言

第16章お問い合わせと免責事項